Select Medical Stockholders Approve Acquisition by Investor Consortium
Stockholders of Select Medical Holdings Corporation voted to approve the company’s acquisition by an investor consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS). The vote, which took place on June 26, 2026, authorizes the transition of the healthcare provider into a privately held entity under the leadership of the purchasing group.
The approval follows the terms of the merger agreement previously negotiated between the company’s board of directors and the consortium. Under the finalized deal, the investor group acquires all outstanding shares of Select Medical common stock. The transaction marks a shift in the company’s corporate structure, moving it away from its status as a publicly traded firm. The company expects to finalize the closing procedures in the coming period, subject to customary regulatory requirements and closing conditions.
Newsflash | Powered by GeneOnline AI
Source: GO-AI-ne1
For any suggestion and feedback, please contact us.
Date: June 26, 2026
©www.geneonline.com All rights reserved. Collaborate with us: [email protected]





